Patients who have received negative results from previous limited testing (e.g., single gene and/or no deletion/duplication analysis) and who are interested in pursuing additional testing should proceed to the succeeding sections to determine if they meet criteria.
Does your patient have any of the following?
1) Tumor profiling test result that shows a mutation (pathogenic/likely pathogenic variant) in a gene that is associated with hereditary cancer when found in a person’s germline cells, or
2) Blood relative with a known mutation (pathogenic or likely pathogenic variant) in a cancer susceptibility gene such as BRCA1, BRCA2, the Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM), adenomatous polyposis gene (APC) or others.
Has your patient ever been diagnosed with cancer or polyps?